Chairman Urges More Careful Treatment

U.S. Senator Daniel K. Akaka (D-HI), Chairman of the Veterans' Affairs Committee, recently issued a statement urging caution regarding the Department of Veterans Affairs' research on smoking and post-traumatic stress disorder (PTSD). Media outlets reported that the VA is testing a drug with potentially dangerous side effects on veterans, including returning servicemembers with mental health disorders. At issue is whether VA should have notified study participants in November 2007, when the FDA first learned of Chantix's side-effects, which include suicidal thoughts, and aggressive and erratic behavior. The Department VA issued a statement on its Smoking Cessation Research Program.

Email this page | Subscribe to Benefits Update |